News and Trends 15 Dec 2022 Solve Therapeutics launches to tackle cancer …reviewing other potential in-licensing opportunities as well as performing in-house antibody discovery research. The company’s focus is on the development of novel mAbs, antibody drug conjugates incorporating next-generation linker and… December 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Sep 2017 A Swedish-Spanish Team Takes on a New Immuno-Oncology Target …cells and can promote the survival, expansion and activity of these immune cells specialized in fighting cancer. Alligator Bioscience already has two antibody candidates in its pipeline that target… September 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jul 2022 Trial for drug targeting cancerous tumors begins in China …(July 15). It is the thirteenth innovative oncology drug candidate discovered in-house by HUTCHMED and it is the company’s second large molecule drug candidate to enter clinical studies. The investigational… July 18, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials …care from chemotherapy to novel targeted therapies. At ASCO 2024, AbbVie’s antibody drug conjugate (ADC) platform was revealed, as the drugs are being developed to target solid tumors. A few… June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Apr 2024 Eight biotech companies you should know about in Austria …most advanced is the chronic inflammation candidate ON104, which is a monoclonal antibody that helps override the immunosuppressive effects of glucocorticoids and neutralize the effects of oxMIF. ON104 is in… April 9, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2023 CatalYm shows importance of GDF-15 in tumor immunotherapy resistance …further highlight the therapeutic significance of its proprietary anti-GDF-15 antibody candidate, visugromab, currently in advanced phase 2 clinical studies. The foundational research, which was performed with founder Jörg Wischhusen and… July 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2020 French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy …lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to… January 9, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 29 Nov 2022 LAG-3: The next big checkpoint inhibitor target …patients the convenience of an oral tablet at a fraction of the cost of existing anti-LAG-3 antibody candidates. Why has this checkpoint target been struggling for a long time to… November 29, 2022 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2016 Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments? …If Lilly’s luck has run dry, Biogen may pick up the baton. Its antibody candidate, aducanumab, is in Phase III trials and was just reported to have decreased A-beta plaques… December 19, 2016 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2025 Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground Earlier this week, Star Therapeutics’ von Willebrand disease candidate – VGA039 – was granted Fast Track designation by the U.S. Food and Drug Administration (FDA). While it is the most… January 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2017 What are the Best Countries to Recruit Biotech Talents in 2017? …in Europe. Molecular Partners develops a new class of small protein therapeutics, with a market cap of €395M. Neurimmune develops antibody therapeutics for age-related diseases and has a candidate in… March 15, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 3 Jun 2025 How biotechs are developing novel treatments to tackle high cholesterol …cholesterol medicines to the market, with a variety of candidates currently in the pipeline. Table of contents A growing trend: Targeting the ANGPTL3 gene to reduce cholesterol levels Several new… June 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email